Introduction
Gastrointestinal damage induced by non-steroidal antiinflammatory drugs (NSAIDs) is one of the most frequent adverse effects. These changes are presumably due to inhibition of Cyclooxygenase (COX), which is responsible for conversion of arachidonic acid to prostaglandin (PGs) that are needed to maintain the integrity of gastric mucosa [1] . It is well recognized that patients taking indomethacin or other NSAIDs for inflammatory disorders such as rheumatoid arthritis and ankylosing spondylitis are likely to develop gastrointestinal mucosal injury. A number of mechanisms have been proposed to explain the mucosal damage induced by NSAIDs, most of which relate to the ability of these drugs to attenuate the synthesis of PGs [2] . However, there is an evidence that COX inhibition by NSAIDs diverting arachidonic acid metabolism to 5-lipoxygenase pathway, suggests the possible role of leukotrienes (LTs) in vascular changes and mucosal damage associated with the use of NSAIDs. Thus, dual inhibitors of COX/LOX pathway, which would be gastro friendly was developed. However, role of LTs in NSAIDs induced gastropathy is debatable. Both supporting and opposing reports on the effect of 5-LOX inhibitor and leukotriene receptor antagonists (LTRA) against NSAIDs induced gastric damage are available [3] . Montelukast 
Experimental design
The rats were randomly divided into 4 groups with 6 4 respectively, and control group received 0.1% Tween solution.
Visual gastric lesions and gastric lesion score
Ulcers were induced by a single oral dose of indomethacin, 100 mg/kg b.w., dissolving in distilled water administered after 4 h fasting of the rats. After 4 h of indomethacin administration, all animals were sacrificed and stomachs were excised along its greater curvature. After rinsing with normal saline, the mucosas were examined for the presence of petechiae or frank hemorrhage lesions. Lesions were scored according to their length (a score of 5 for lesions with length between 1 and 3 mm; a score of 10 for lesions greater than 3 mm). The sums of total scores were used for comparison [4] . All treatment groups were coded to prevent measurement bias.
Determination of malondialdehyde (MDA) levels in gastric tissues
MDA levels in the gastric tissue were measured by the method developed by Ohkawa et al. [5] Lipid peroxidation is estimated in terms of TBAR species using MDA as standard.
About 1 mL of homogenized gastric tissue in 2 mL of normal saline was mixed with 24 % TCA and centrifuged at 2 000 rpm for 20 min. To 2 mL of protein-free supernatant, 1mL of fresh TBA 0.67% reagent was added, mixed thoroughly and heated at 95˚C for 1 h in a water-bath. The suspension was then cooled to room temperature, centrifuged at 2 000 rpm for 10 min and the pink colored supernatant was taken for spectroscopic measurement at 532 nm for the assay of MDA. Lipid peroxide was expressed in terms of nm of MDA/gram of gastric tissue.
Determination of percent neutrophil adhesion
After 60 min of indomethacin administration blood was collected from retro-orbital plexus into heparinised vials and analyzed for total leukocyte count. The differential leukocyte count was performed by fixing the blood samples and staining the LTs and percent neutrophils in each sample was determined. After the initial counts, blood samples were incubated with 80 mg/ml of nylon fibers for 10 mins at 37°C. The incubated blood samples were again analyzed for total leukocyte count and differential leukocyte count [6] .
The product of total leukocyte count and percent neutrophils gave the neutrophil index of blood sample. Percent neutrophil adhesion was calculated from the following formula [6] :
Neutrophil adhesion (%) = (Nlu -Nlt)/Nlu
Where, Nlu = Neutrophil index of untreated blood sample; and Nlt = Neutrophil index of treated blood sample.
Determination of vascular permeability
The ventral sides of the animals were shaved. Five ml/kg of a 1% solution of Evan's blue was injected intravenously. One hour later the animals were dosed with the test compound orally or intraperitoneally with the vehicle. Thirty minutes later, the animals were briefly anaesthetized with ether and compound 48/80 was injected intracutaneously at 3 sites both at left and ventral side. Ninety minutes after the injection of compound 48/80, the animals were sacrificed by ether anesthesia [7] . The abdominal skin was removed and the dye was extracted.
Method for the extraction of extravasated dye in the skin
A piece of the skin containing extravasated dye was soaked overnight in a Stoppard glass tube containing 1 mL of 1 N KOH at 37˚C. Then, 9 mL of mixed solution (5:13) of 0.6 N H3PO4 and acetone is added to the tube. The tube is shaken vigorously for a few seconds and centrifuged at 3 000 rpm for 15 mins. Absorbance of supernatant is measured at 620 nm [8] .
Statistical analysis
The results are expressed as mean ± SD. Differences in all the parameters were determined by factorial one-way analysis of variance. Individual groups were compared using Tukey's test. Data were considered significant when P<0.05. Statistical analysis was performed using Graph Pad Prism software (version 5).
Results

Visual gastric lesions
Indomethacin produced significant number of gastric lesions 4 h after dosing. Montelukast 
Effect of Montelukast and curcumin on gastric lesion score
The gastric lesion score was 43 
Effect of Montelukast and curcumin on induced percent neutrophil adhesion
In another study, 1 
Measurement of lipid peroxides as TBARS
The level of TBAR substances (index of lipid peroxidation) of gastric mucosa was 16 
Vascular Permeability Study
The vascularity of the skin derived from Evan's blue administration was assessed after acute administration of indomethacin and pretreatment with Montelukast and curcumin. Indomethacin resulted in significant (P<0.001) increase in vascularity index when compared to control group. Montelukast and curcumin significantly (P<0.05 and P<0.001, respectively) reversed indomethacin (100 mg/kg) induced vascular permeability (Table 1) . 
Discussion
Long-term use of NSAIDs is the second most common cause of ulcers and the rate of NSAID induced ulcers is increasing, which presumably cause ulcers by disrupting mucosal defense and repair mechanisms.
Gastric lesion score
In the present study, NSAIDs, indomethacin, a nonselective COX inhibitor caused significant gastric ulcers by inhibiting the COX enzyme and thereby, reducing the synthesis of PGs. Inhibition of PGs synthesis can exert injurious actions on the gastric and duodenal mucosa as it abrogates a number of prostaglandin dependent defense mechanisms.
Inhibition of COX decreases mucus and bicarbonate secretion, reduces mucosal blood flow, and causes vascular injury, leukocyte accumulation, and reduces cell turnover. All these factors contribute to the genesis of mucosal damage (Halter et al., 2001 ). In the present study, Montelukast and curcumin significantly reduced gastric lesion score. COX inhibition by NSAIDs diverts arachidonic acid metabolism to 5-LOX pathway, suggests the possible role of LTs in vascular changes and mucosal damage [9] . So, it indicates that Montelukast and curcumin may reduce gastric ulcers by inhibiting the production of LTs. In support, recent study reported that Montelukast has shown anti-secretory, antiapoptotic effects on pyloric ligation and water immersion stress induced peptic ulcer in rats [10] . In another study, Tepoxalin, a COX/LOX dual inhibitor was reported to prevent gastrointestinal ulceration when given 30 min prior to indomethacin treatment [11] .
Percentage of neutrophil adhesion and lipid peroxidation
Neutrophils have been implicated as mediators of the epithelial cell and microvascular dysfunction associated with several models of gastrointestinal mucosal injury. The circulating activated neutrophils appeared to be important in the development of gastric erosions and changes in vascular integrity following NSAIDs gastropathy [12, 13] . Also, the role of neutrophil derived oxygen free radicals in NSAIDs induced disruption of gastric membrane integrity is documented [14] . Recent study reported the gastroprotective effect of leukotriene receptor blocker montelukast in alendronetinduced lesions of the rat gastric mucosa [14] [15] [16] [17] .
In the present study, Montelukast and curcumin have significantly inhibited the indomethacin induced neutrophil adhesion and this thereby decreasing the gastric ulceration [18] [19] [20] . This was clearly evident from the decreased gastric lesion score. This was also further supported by the study, Licofelone, a novel 5-LOX/COX-inhibitor, attenuates leukocyte rolling and adhesion on endothelium under flow [22] . In the present study, indomethacin caused significant increase in TBARs as compared to control. LTB4 can also stimulate the release of reactive oxygen metabolites from neutrophils, which contributes significantly to the tissue injury associated with mucosal inflammation [23] . Montelukast and Curcumin significantly decreased the elevated levels of TBAR species. This is further supported by another study, Licofelone, significantly reduced increase in TBAR species [22] .
Vascular permeability
Our result is further supported by Drewe et al. (2001 ) [24] which enhances paracellular permeability and epithelial destruction [25] . Oxygen radicals (superoxide of a secondary radical) are involved in the intestinal vascular permeability changes induced by ischemia. A study by Bliskslager et al. (2002) [26] showed that Ischemic injured tissues recovered to control levels of resistance within three hours where as tissues treated with Indomethacin failed to fully recover. Indomethacin caused significant increase in vascularity index as compared to control. Pretreatment with Licofelone, significantly reduced vascular permeability [27] . In accordance with the previous findings, the present study demonstrated that Montelukast and curcumin also attenuated increased vascularity in rats.
So, Montelukast and curcumin offers the gastroprotection by inhibition of neutrophil adhesion and hence reduced generation of free radicals and vascular permeability.
In support of our results, Rainsford (1987) studies revealed that the multifactorial basis of gastro-intestinal (GI) damage from NSAIDs includes effects of these drugs in producing microvascular injury. Increased 5-lipoxygenase activity reflected in production in the gastric efferent circulation of leukotriene C4 was shown in pigs given i.g. indomethacin. Blockade of 5-LOX activity by highly selective inhibitors of this enzyme inhibits production of both gastric and intestinal LT in rats and mice [11] .
The data strongly suggest that Montelukast and curcumin conferred gastro protection by inhibiting the indomethacin induced increase in 5-LOX effectors. The results of the present study further indicates the role of 5-LOX metabolites in gastro inflammation and suggests that Montelukast and curcumin counteract the gastropathy by a combination of its effect on inhibition of neutrophil adherence and through decrease in related production of free radicals that disrupts integrity of stomach mucosa. However 
